CALCR and neuroendocrine neoplasm: Some studies have shown that the expression of CALCR is increased in neuroendocrine tumors and chronic pancreatitis, and it may inhibit the progression of glioblastoma through the CT-CALCR signal axis (Pal et al., 2018).